# Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction.

> **NCT00324766** · PHASE4 · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 61 (actual)

## Conditions studied

- Myocardial Infarction
- Heart Failure
- Cardiogenic Shock

## Interventions

- **DRUG:** levosimendan
- **DRUG:** placebo,

## Key facts

- **NCT ID:** NCT00324766
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2011-09
- **Final completion:** 2012-03
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2012-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00324766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00324766, "Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00324766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*